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Patterns of HIV testing, drug use, 
and sexual behaviors in people who use drugs: 
findings from a community-based outreach 
program in Phnom Penh, Cambodia
Gitau Mburu1, Chanrith Ngin2, Sovannary Tuot2, Pheak Chhoun2, Khuondyla Pal2 and Siyan Yi2,3*
Abstract 
Background: People who use drugs are an important priority for HIV programs. However, data related to their utiliza-
tion of HIV services are limited. This paper reports patterns of HIV testing, drug use, and risk and service perception 
among people who use drugs. Study participants were receiving HIV and harm reduction services from a community-
based program in Phnom Penh, comprised of itinerant peer-led outreach and static drop-in centers.
Methods: This was a mixed-methods study conducted in 2014, comprising of a quantitative survey using a struc-
tured questionnaire, followed by two focus group discussions among a sub-sample of survey participants. Participants 
were recruited from hotspots in five HIV high-burden communes using a two-stage cluster sampling method. Quanti-
tative descriptive analyses and qualitative thematic analyses were performed.
Results: This study included 151 people who use drugs with a mean age of 31.2 (SD = 6.5) years; 77.5% were male 
and 39.1% were married. The most common drugs used were methamphetamines (72.8%) and heroin (39.7%), and 
38.0% injected drugs in the past 3 months. Overall, 83.3% had been tested for HIV in the past 6 months, of whom 
62.5% had been tested by peers through community-based outreach. However, there were ongoing HIV risks: 37.3% 
were engaging in sex on drugs, only 35.6% used a condom at last sexual intercourse, and 10.8% had had a sexually 
transmitted infection in the last 6 months. Among people who reported injecting drugs in the past 3 months, 27.5% 
reported re-using needles/syringes. Almost half (46.5%) perceived themselves as being at lower risk of HIV compared 
to the general population. Qualitative results contextualized the findings of low perception of HIV risks and suggested 
that although services were often unavailable on weekends, at night, or during national holidays, peer-led commu-
nity-based outreach was highly accepted.
Conclusions: A peer-led community-based approach was effective in reaching people who use drugs with HIV and 
harm reduction interventions. To mitigate ongoing HIV risks, expanding access to combination prevention interven-
tions and implementing strategies to enable people who use drugs to objectively assess their HIV risks are required. 
Additionally, community-based programs should collect data along the care continuum, to enable decentralized 
tracking of progress towards 90–90–90 goals at local levels.
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Background
Prompt HIV diagnosis, timely linkage to care, early treat-
ment, retention in care, and sustained viral suppres-
sion are all essential for optimal impact of antiretroviral 
therapy (ART) in reducing morbidity and mortality from 
human immunodeficiency virus (HIV) [1–4]. The time-
sensitive sequencing of clinical and operational events 
that commence with an HIV diagnosis and end with long 
term viral suppression epitomize the continuum of HIV 
care [5].
However, significant loss to follow-up of people living 
with HIV occurs in the various steps between HIV test-
ing and viral suppression [6, 7], resulting in an undesir-
able cascade [5]. Hence, a paradigm shift focusing on 
proportions of people living with HIV that are tested, 
linked to care, retained in care, adherent to ART, and 
achieving sustained viral suppression is increasingly 
framing outcomes of HIV care. The UNAIDS 90–90–90 
targets, which aim to ensure that 90% of all people liv-
ing with HIV know their status, 90% of all diagnosed peo-
ple living with HIV receive ART, and 90% of all persons 
receiving ART achieve viral suppression [8], capture this 
paradigm shift.
Achievement of these global goals will depend on their 
attainment among all people living with HIV and key 
populations including people who use drugs [9]. Peo-
ple who use drugs constitute one of the most vulnerable 
populations to HIV. Unsafe drug use accounts for a third 
of newly diagnosed HIV infections outside sub-Saharan 
Africa [10], and 10% of all HIV infections globally [11]. 
Drug use is particularly widespread in Asia [12], and its 
impact on HIV is increasing [13]. In Cambodia, where 
the national HIV prevalence is 0.3% among the general 
population, people who use drugs are disproportionately 
affected, with a prevalence of 4.0% among people who 
use non-injecting drugs and 24.8% among individuals 
who inject them [14].
Given the importance of people who use drugs in the 
global HIV epidemic, it is essential that early testing, 
linkage, retention, and viral suppression are achieved 
among these groups. Currently, however, very few coun-
tries are well poised to attain the 90–90–90 targets in 
people who use drugs by 2020. A recent review revealed 
a significant lack of data related to HIV care continuum 
among people who use drugs. In the few countries where 
data are available, care outcomes among people who use 
drugs are significantly below 90–90–90 targets [9]. Indi-
vidual studies have reported that people who use drugs 
have low rates of ART coverage [15], HIV testing [9], 
adherence [16], retention [17], and viral suppression [9, 
17]. Although contextual differences exist, these poor 
outcomes are generally caused by a range of individual, 
social, legal, health system, and other structural barriers 
[13, 18, 19]. In addition, effective models for promoting 
the widespread reach and entry of people who use drugs 
into HIV care are generally limited globally [20].
Cambodian national response has placed an emphasis 
on key populations, including people who use drugs, in 
order to achieve the 90–90–90 target and eliminate new 
HIV infections under Cambodia 3.0 [21]. A recent review 
reported that, of the estimated 72,607 people living with 
HIV, 60,336 (83%) are diagnosed, 54,769 (75%) are receiv-
ing ART, and 50,935 (70%) are virally suppressed. As 
such, Cambodia is one of the few countries on track to 
achieve 90–90–90 targets [22]. However, this review did 
not evaluate care continuums for specific populations 
(e.g., key populations), which—authors assert—would 
more directly inform programming strategies for these 
populations [22].
In Cambodia, there are still gaps in the data and stra-
tegic information on the HIV situation and response, 
in particular among key affected populations [23]. The 
national estimated number of people who use non-
injecting drugs and people who inject drugs was 13,000 
and 1300, respectively [14]. However, precise 90–90–90 
estimates among these populations are unavailable. Like 
many other countries, strategic information in each step 
along the continuum for people who use drugs is limited 
[14]. One of the five key objectives of the National Strate-
gic Plan on Harm Reduction is strengthening the strate-
gic information base [23].
In this paper, we report patterns of HIV testing, drug 
use, and sexual behaviors among people who use drugs 
who were receiving HIV and harm reduction services 
from a community-based HIV program in Phnom Penh. 
We also report their self-perception of HIV risk and 
views regarding community-based services they were 
receiving, in order to provide information that could 
improve services for this population. We conclude this 
paper with a brief discussion of the potential implica-




This was a mixed-methods study that was composed of 
a large quantitative cross sectional survey, with a smaller 
qualitative component comprising focus group discus-
sions (FGDs).
Study settings
The research was conducted among people who use 
drugs in Phnom Penh, who were in contact with a com-
munity-based program known as Sustainable Action 
against HIV and AIDS in Communities (SAHACOM). 
SAHACOM was implemented over a 5-year period 
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ending in December 2014, focusing on key populations 
[24, 25]. The project was implemented by KHANA, 
a leading HIV non-governmental organization work-
ing through numerous community-based organizations 
(CBOs).
The project utilized a community-based approach to 
empower and create ownership of the project among key 
populations, including people who use drugs. The model 
was composed of itinerant peer-based outreach, and static 
drop-in centers. Through this model, key population peers 
were hired by CBOs to provide HIV and harm reduction 
services to people who use drugs, including HIV educa-
tion, condoms, clean needles, and syringes. Through peer 
involvement, the model transformed people who cur-
rently or formerly used drugs from passive service recipi-
ents to active providers of services [26].
Besides providing the above services in their own local-
ities, peers referred people who use drugs to the static 
drop-in centers, which were part of community-level 
infrastructure, where methadone, harm reduction coun-
selling, peer discussions, personal care, needles, syringes, 
and condoms, among other commodities, were provided. 
In addition, people who use drugs in contact with the 
outreach teams were encouraged to form and attend peer 
discussions at drop-in centers for education purposes.
At the end of the implementation period, data were 
collected to assist in evaluation of the project. The pur-
pose of the evaluation was to understand the HIV testing 
and prevention needs of the participants, and their per-
ception of the SAHACOM services. Mixed methods were 
used to allow contextualization of quantitative survey 
data. This is a widely used approach of linking quantita-
tive and qualitative data within implementation research 
[27, 28].
Participant selection
By the time the SAHACOM was implemented, the esti-
mated total number of people who use drugs in Phnom 
Penh was 4188; of these 1068 injected drugs. In Phnom 
Penh, SAHACOM was implemented in 33 communes 
with high concentration of people who use drugs out of 
96 communes in the city. Although accurate general pop-
ulation size for these communes was not available, stra-
tegic information related to HIV suggested that these 33 
communes covered approximately 1969 people who use 
drugs, of whom 353 injected drugs. A two-stage cluster 
sampling method was used to select participants for the 
quantitative component. At the first stage, the research 
team identified five communes with at least 20 peo-
ple who use drugs to be included in the study. A list of 
‘hotspots’ where people who use drugs and congregated 
was made based on geographical clustering of high risk 
behaviors as is practiced elsewhere [29]. At the second 
stage, all people who use drugs in the selected hotspots 
were approached and invited to participate in the study, 
and were screened for eligibility.
Potential participants were included in the study if 
they: (1) were at least 18  years of age, (2) had used any 
form of illicit drugs in the past 3 months, (3) were able 
to present themselves on the day of the interview, and (4) 
were able to provide informed consent to participate in 
the study. Of the 192 people screened, 22 were excluded, 
leaving 170 eligible participants. For the qualitative com-
ponent, a convenience-based subsample was selected 
from the primary participants in the quantitative phase. 
At the end of quantitative data collection, participants 
were invited to take part in focus group discussions based 
on interest, convenience, availability, and willingness to 
consent. The participant selection process is illustrated in 
Fig. 1.
Study tools development
The quantitative questionnaire was developed in Eng-
lish, translated into Khmer, back-translated to English, 
and pretested to ensure that it was culturally suitable 
and clearly understandable. Standardized questions 
were adapted from previous studies and Demographic 
and Health Surveys [14, 30, 31] to document partici-
pants’ socio-demographic characteristics (e.g. age, sex, 
marital status, education, occupation, income, resi-
dence, and mobility), drug use characteristics (e.g. age 
of initiation, frequency, method and types and circum-
stances of drug use, sharing of needles or syringes, as 
well as history of drug-related arrests and voluntary 
rehabilitation or incarceration/imprisonment), HIV-
related characteristics (e.g. prior HIV testing, venue of 
HIV testing and counselling, and sources of HIV edu-
cation), sexual behaviors (e.g. sexual activity, number 
of sex partners, consistency of condom use, history of 
STI symptoms, whether STI treatment was sought, and 
nature of facility from which treatment for STI was 
sought), and self-perceived risk of HIV. To get a sense 
of participants’ self-perceived risk of HIV, participants 
were asked to indicate whether they thought they 
were at lower, same, or higher risk, relative the general 
population.
Similarly, a topic guide for qualitative focus groups 
was developed in English, translated into Khmer, back-
translated to English, pretested, and adjusted accordingly 
following piloting. The objective of the qualitative com-
ponent was to contextualize and provide insights to the 
quantitative findings. The focus group topic guide ques-
tions were open ended and explored participants’ drug 
use behaviors, HIV testing experiences, sexual behaviors, 
perceived risk of HIV, and perception of services they 
were receiving through the SAHACOM.
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Data collection
Data were collected by researchers in private rooms in 
drop-in centers. Before data collection, researchers were 
provided with an overview of the study objectives and 
trained on the questionnaire filling techniques including 
error checking, focus group facilitation, privacy assurance, 
confidentiality, and data protection. Questionnaires were 
administered face-to-face to 170 participants, each lasting 
30–45  min. At the end of survey questionnaires, partici-
pants were invited to participate in the focus groups.
Interested and consenting participants were provided 
with appointment schedules to attend the discussions. 
Invitation to take part in the focus groups was not based 
on types of drugs used, as long as participants had partic-
ipated in the quantitative survey. In total, two focus group 
sessions, each with six participants, were conducted on 
the premises of CBOs. Recruitment for the focus groups 
was guided by saturation of themes, rather than by pre-
specified sample size as recommended in qualitative 
studies [32]. At the end of the second focus group ses-
sion, it was clear that additional discussions would not 
yield further insights and recruitment was halted. The 
focus groups lasted 45–60 min, were tape-recorded, and 
were conducted in the local Khmer language.
Data analyses
Quantitative data were coded and entered into a com-
puter using Epi Data version 3 (Odense, Denmark). Dou-
ble data entry was performed to limit errors. Logic checks 
were performed, and 19 participants who reported that 
they had not used any illicit drugs in the past 3 months 
were excluded from the analyses. Summary of frequen-
cies for nominal and ordinal variables was documented. 
Descriptive analyses were used to compute means for 
continuous variables. SPSS version 20.0 (IBM Corpora-
tion, New York, USA) was used for all data analyses.
Qualitative audio data were transcribed and transcripts 
translated to English from Khmer and imported into 
NVivo (QSR International). Thematic data analysis [33] 
was then conducted inductively within the original aims 
of the study, in order to provide context for the quanti-
tative findings regarding sexual and injecting behaviors, 
nature of services received by participants, and partici-
pants’ perception of those services. Nodes were created, 
and populated with appropriately labelled codes. Codes 
were populated with textual segments refined using con-
stant comparison approach [34], and then categorized 
based on similarities to generate overarching themes [32, 
33]. Verbatim quotes were extracted from participants’ 
transcripts and displayed in the text to aid transparency 
of interpretation as recommended [35]. Qualitative text 
and quotes were presented alongside quantitative data 
in order to contextualize or explain survey findings in an 
integrated fashion [36].
Ethical considerations
This study was approved by the National Ethics Com-
mittee for Health Research (No. 082NECHR). Verbal 
consent was obtained from each participant. Before 
consenting, participants were informed of their right to 
discontinue their participation at any time, without any 
consequences. Names and contact information of the 
researchers were provided to participants for use in case 
Excluded: 
• Did not reside in the program
coverage area (n= 2,285)
Total esmated number of people 
who use drugs in Phnom Penh
(n= 4,188)
Approached and screened 
(n= 192)
Excluded: 
• Did not fulfil eligibility 
criteria (n= 22)
Completed the quantave 
survey (n= 170)
A sub-sample parcipated in 
focus groups (n= 12)
Data 
presented 
jointly in this 
manuscript
Total number of people who 
use drugs in 33 communes 
under SAHACOM coverage (n= 
1,969)
Number of communes with ≥ 
20 people who use drugs and 
included in sampling (n= 05)
Included in data analyses
(n= 151)
Excluded in data analyses: 
• Reported not using drugs in 
the past 3 months (n= 19)
Fig. 1 Participant selection process
Page 5 of 10Mburu et al. Addict Sci Clin Pract  (2017) 12:27 
they had any questions. Identifiable data were not col-
lected on questionnaires; instead, unique codes were uti-
lized in order to protect confidentiality of participants. 
Participant were compensated approximately US$5 for 
their time and transport to participate in the study.
Results
Socio‑demographic characteristics
In total, 151 people who use drugs participated in the 
survey, whose mean age was 31.2 (SD  =  6.5) years; a 
subsample of whom (n =  12) participated in the focus 
groups. Of the total participants, 77.5% were male; 39.1% 
were married, 40.4% were single, and 20.5% were either 
divorced or widowed. In addition, 14.6% were unem-
ployed, and the sample was generally non-migratory, hav-
ing lived in their current locations for a mean of 19 years 
(Table 1).
Drug use practices
As shown in Table 2, 38.0% of the total participants had 
injected drugs in the past 3 months. On average, partic-
ipants started using drugs at the age of 21.3 (SD =  6.5) 
years, and had used drugs for the past 8.4 years. The most 
common drugs used were amphetamines (72.8%) and 
heroin (39.7%). Although most participants used drugs 
either with friends (54.4%) or alone (31.1%), a notable 
proportion (14.5%) used drugs with their sexual partners. 
More than half (55.3%) of the overall sample had been 
referred to a rehabilitation center in their lifetime, and 
21.9% had been sent to the center in the past 12 months. 
A third (31.3%) had ever been incarcerated/imprisoned 
due to drug possession and other offences.
Less than a third (27.5%) of participants who injected 
drugs in the past 3 months reported that they had used a 
needle that had been used by someone else the last time 
they injected. Contextualizing this finding a participant 
explained that, “we stopped sharing syringe…we try to 
prevent it” (respondent # 1, focus group 1), while another 
asserted that, “we take a methadone regularly, stopped 
injecting and stopped sharing syringes” (respondent # 4, 
focus group 1). Participants mentioned that peer educa-
tors were an important source of syringes for the partici-
pants. Besides commodity supplies, participants relied on 
peer educators for “transportation service to get metha-
done” (respondent # 4, focus group 1).
However, participants raised concerns regarding a lack 
of supplies on weekends or other days when national hol-
idays and ceremonies were being held. One participant 
asserted that, “on Saturday and Sunday, if we don’t have, 
we need to buy” (respondent # 6, focus group 1), because 
as explained by another participant, “they just don’t work 
at weekends but Monday to Friday they come to meet 
people at local” (respondent # 5, focus group 1). Partici-
pants also explained that re-using or sharing needles was 
common at night when getting syringes or needles was 
limited:
“Sometimes, people inject around 12 or 1 at night, so 
during that time no one comes to provide you syringes or 
needles” (respondent # 2, focus group 2).
Despite this gap in service provision, participants 
asserted the value of outreach suggesting that, “they do 
not come and provide services all the time; however, their 
services reduce the cost of our expenses” (respondent # 2, 
focus group 1).
HIV counselling and testing
As shown in Table  3, 96.0% had ever been tested for 
HIV in lifetime, and 83.3% had received an HIV test in 
the past 6 months. In addition, 97.2% had received coun-
selling during their most recent HIV test. A majority 
(62.5%) of the HIV testing was delivered through com-
munity- or peer-initiated counseling and testing, with 
a minority (9.0%) having been provided through volun-
tary counseling and testing centers. In addition, 86.6% 
had received HIV education in the past 12 months, and 
although most participants received this information 
Table 1 Socio-demographic characteristics of participants
SD standard deviation
Variables Number (%)
Mean age (years, ±SD) 31.2 ± 6.5
Gender
 Male 117 (77.5)
 Female 34 (22.5)
Marital status
 Married 59 (39.1)
 Divorced, widow 31 (20.5)
 Single 61 (40.4)
Mean years of schooling completed (±SD) 5.2 ± 4.1
Main occupation
 Unemployed 22 (14.6)
 Laborer 33 (21.9)
 Self-employed business 45 (29.8)
 Office worker 10 (6.6)
 Other 41 (27.2)
Monthly income (US$, ±SD) 313.7 ± 601.0
Currently living with:
 Parents 41 (27.2)
 Spouse/partner 60 (37.7)
 Friend/colleagues 19 (12.6)
 Siblings/relatives 14 (9.3)
 Alone 17 (11.3)
Mean length of residency in Phnom Penh (in months, 
±SD)
233.6 ± 149.3
Page 6 of 10Mburu et al. Addict Sci Clin Pract  (2017) 12:27 
from several different sources, the most common source 
of HIV education was peer educators or outreach work-
ers (89.2%). These qualitative data suggested that com-
munity-based outreach program was an important 
source of HIV education, counselling and testing which 
was relatively acceptable to participants.
Contextualizing these findings, qualitative focus groups 
supported the view that HIV testing and education pro-
vided by peers and outreach workers were acceptable to 
participants. Referring to these peers and outreach work-
ers, a focus group participant affirmed that, “they help us 
to know that we are reactive HIV…. if we are HIV positive 
we go to get ART” (respondent # 1, focus group 2). This 
participant further commented that, “the organization 
always comes to educate us.” (respondent # 1 focus group 
2), while others contrasted access to testing in health 
facilities by asserting that they found outreach services 
easily accessible “because they come two times per day” 
(respondent # 6, focus group 2).
Sexual behaviors
As shown in Table 4, 37.3% of the participants reported 
having sex while intoxicated with drugs. In addi-
tion, 10.8% had been diagnosed with an STI in the past 
6 months. At the same time, 41.1% reported having been 
involved in sexual intercourse in the past 3 months, and 
only 35.6% reported using a condom in their last sexual 
intercourse act.
Table 2 Drug use practices among the study participants
Variables Number (%)
Type of drugs used in the past 3 months
 Methamphetamines 110 (72.8)
 Heroin 60 (39.7)
 Other (ecstasy, sniffed glue, marijuana, etc.) 5 (3.3)
Mean duration of drug use (months, ±SD) 103.8 ± 68.7
Mean age at first time of illicit drug use (years, ±SD) 21.3 ± 6.5
Frequency of illicit drug in the past 3 months
 Everyday 77 (51.3)
 Almost everyday 21 (14.0)
 A few times a month 24 (16.0)
 A few times a week 27 (18.0)
People with whom you used drugs the last time
 Alone 47 (31.1)
 Friend 82 (54.4)
 Sexual partner/sweetheart 22 (14.5)
Reason to led you try illicit drugs for the first time
 I tried it by myself 45 (29.8)
 Someone gave it to me or forced me to use it 6 (4.0)
 Tried it with friends 81 (53.6)
 Other 19 (12.6)
Injected drugs in the past 3 months 57 (38.0)
Used a used needle when injected drugs the last time 
(n = 57)
14 (27.5)
Shared needles at last drug injection (n = 57) 8 (15.7)
Perceived that needle/syringes are easy to find (n = 57) 50 (87.7)
Have been arrested for drug use or trafficking 70 (46.4)
Have ever been sent to a drug rehabilitation center 83 (55.3)
Have been sent to a rehabilitation center in the past 1 year 33 (21.9)
Had ever been incarcerated/imprisoned 50 (33.1)
Main cause of most recent incarceration/imprisonment
 Drug use or possession 11 (22.4)
 Drug-related crimes (e.g. theft) 31 (63.3)
 Other crimes (non-drug related) 7 (14.3)
Table 3 Access to HIV counselling, testing, and education
HIV human immunodeficiency virus
Variables Number (%)
Ever tested for HIV 144 (96.0)
Tested for HIV in the past 6 months (n = 144) 120 (83.3)
Place for last HIV testing (n = 144)
 Voluntary counseling and testing center 13 (9.0)
 Community/peer-initiated testing 90 (62.5)
 Public health center/clinic/hospital 31 (21.5)
 Private clinic/hospital 10 (6.9)
Received result of the most recent HIV test (n = 144) 143 (99.3)
Received counseling for the last HIV test (n = 144) 139 (97.2)
Received HIV education in the past 12 months 129 (86.6)
Source of HIV education in the past 12 months (n = 129)
 Mass media (television/radio/newspaper) 60 (46.2)
 Poster/billboard 34 (26.2)
 Peer educator or outreach worker 116 (89.2)
 Voluntary counseling and testing session 28 (21.5)
 Health staff 43 (33.1)
Self-perceived level HIV risk compared to the general 
population
 Higher 52 (36.1)
 Same 19 (13.2)
 Lower 67 (46.5)
 Don’t know 6 (4.2)
Table 4 Sexual behavior among the study participants
STI sexually transmitted infections
Sexual behaviors Number (%)
Diagnosed with an STI in the past 6 months 16 (10.8)
Sought treatment for most recent STI symptom (n = 16) 2 (11.1)
Facility where the most recent STI was treated
 Public health center/hospital (n = 2) 1 (50.0)
 Non-governmental clinic/hospital (n = 2) 1 (50.0)
Had sexual intercourse in the past 3 months 59 (41.3)
Used condom in last sexual intercourse (n = 59) 21 (35.6)
Had sexual intercourse when intoxicated (n = 59) 22 (37.3)
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Qualitative data provided additional insights regard-
ing the inconsistent condom use. In particular, narra-
tives from the focus groups suggested that participants 
did not believe that they needed to use condoms with 
their spouses because they trusted them. Asked why they 
were not using condoms, participants responded by say-
ing that, “I trust my wife” (respondent # 6, focus group 1), 
“Yes, I believe my wife” (respondent # 5, focus group 1), 
among other similar responses.
HIV risk perception
As shown in Table  3, a majority of participants (56.5%) 
viewed themselves to be at the same or lower risk of HIV 
infection compared to the general population. Although 
there were other reasons for not using condoms, such 
as a “desire to have a child” (respondent # 3, focus group 
1), the finding of low condom use among the sample is 
relevant as it corroborates the low self-perception of 
HIV risk among the participants. While responding to a 
question regarding whether he thought he was at risk of 
HIV, a participant stated that, “I have only my wife, I don’t 
have any other partners” (respondent # 4, focus group 1), 
showing that participants viewed HIV risk as external to 
themselves and their drug-using behaviors.
Further exploration of this issue in the focus groups 
suggested that participants believed that their increased 
knowledge was contributing to their protection from 
HIV, and they were no longer at high risk of HIV. When 
asked whether they thought their group was a high-
risk group, participants contrasted the previous lack of 
knowledge with their current situation, stating that:
“Firstly, we didn’t have a support from NGOs, secondly 
we don’t have a counseling from NGOs and that made 
us lack knowledge about health care or prevention, so it 
made us a high risk group” (respondent # 5, focus group 
2).
This participant, who belonged to a specific peer dis-
cussion group of drug users in one of the drop-in centers 
went on to state that:
“Now, I think my group is a low-risk group, because we 
have a lot of knowledge from NGOs that come to edu-
cate us” (respondent # 5, focus group 2).
These sentiments were supported by others who 
emphasized the changes in risks occurred due to the 
changes in sexual and injecting behaviors, primarily due 
to increased supply of harm reduction commodities. In 
a typical response regarding why they thought they were 
at low risk of HIV, a participant stated that, “previously, 
we didn’t have condoms to use and didn’t have any NGOs 
coming to provide them” (respondent # 2, focus group 2). 
Others also referred to condoms, stating that their HIV 
risk was reduced “because we have NGOs who taught 
about using condoms; now we know how to use it, espe-
cially to prevent STIs” (Respondent # 6, FGD 1).
Apart from availability of condoms, few participants 
also referred to availability of clean syringes as giving 
them a sense that they were at low risk. For instance, 
one participant mentioned that, “as for now, we do not 
have any disease because we use new syringes” (respond-
ent # 1, focus group 1). As can be noted from the above 
excerpts, participants felt that, apart from knowledge 
per se, their use of preventive interventions was protect-
ing them from HIV. Within these discussions, it emerged 
that the use of these comodities was enhanced by their 
free provision:
“Now we have NGOs to provide them, it isn’t like before 
when we didn’t have and we needed to buy” (respondent 
# 4, focus group 1).
Discussion
This paper describes important information regard-
ing access to HIV testing among people who use drugs. 
The study reports a high level of access to HIV testing 
in the context of ongoing injecting and sexual risks, and 
in a country where a quarter of people who inject drugs 
(24.8%) are HIV infected [14]. The high proportion of 
participants who had ever been tested (96.0%), or were 
tested in the last 6  months (83.3%) is notable given the 
generally low rates of testing among people who use 
drugs reported from other settings [9, 37, 38].
A number of factors may have contributed to this 
observation, the most likely being the model of commu-
nity-based outreach, which embraced the deployment 
of community support volunteers, peer facilitators, and 
peer educators to provide services. The majority of those 
who were tested accessed testing from these peer provid-
ers rather than voluntary counseling and testing centers. 
The proportion of participants tested for HIV was high 
despite the perceived low risk of HIV. This approach may 
also have mitigated transport, administrative, attitudinal, 
and trust-related barriers which deter testing of people 
who use drugs in conventional health facilities [39, 40].
The utilization of drop-in centers and community-level 
infrastructure to provide methadone, personal care, coun-
selling and education, needles, syringes, condoms, and 
other commodities may have synergistic effects on the 
uptake of these HIV and harm reduction interventions. 
Qualitative findings suggested that methadone was per-
ceived as providing opportunities to reduce drug inject-
ing, while increasing uptake of clean needles and syringes. 
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These findings endorse the use of methadone to mitigate 
risks [41, 42], and the use of community-based outreach 
model for providing integrated HIV and harm-reduction 
services [43]. Other studies have shown that the use of 
socially familiar infrastructure, such as community-based 
drop-in centers can act in synergy with the use of peer 
counsellors or educators or outreach workers to enhance 
HIV testing, entry into HIV care, and uptake of harm-
reduction interventions [20, 39, 44, 45].
In spite of the close contact with peer-based outreach 
services, our findings highlighted ongoing risks of HIV 
infection among the study sample. Study participants 
believed that their knowledge of HIV and adoption of 
safer injecting practices reduced their risk of HIV. While 
this might be the case, participants were still exposed to 
significant risks. The low perceived level of risk, com-
bined with a low rate of condom use among those who 
are sexually active, engagement in sex while intoxicated, 
and the occasional sharing of needles, operate together to 
escalate potential for HIV infection.
These enduring risks suggest a need for additional pre-
vention interventions and delivery strategies tailored to 
participants’ risk profile. For instance, despite the advan-
tages of peer outreach model, a lack of outreach services 
over weekends, nights, and bank holidays increased risky 
injecting behaviors. While firm conclusions may not be 
made about the impact of these gaps, these findings sug-
gest a need for innovative methods such as self-dispensing 
or vending machines for needles and syringes for partici-
pants who encounter these temporal shortages. On the 
other hand, PrEP might be useful in situations where con-
dom use is intended but does not occur, which is relevant 
for couples, given that almost half of the participants were 
in stable relationships yet condom use with spouses was 
sub-optimal.
In addition, a sixth of participants used drugs with 
their sexual partners, further lending weight to other calls 
that testing and prevention services should be extended 
to sexual partners of people who use drugs [46]. Use of 
methamphetamine and other drugs during sex, colloqui-
ally termed ‘chemsex,’ is associated with higher sexual HIV 
transmission risks [47, 48], and requires to be addressed 
through specifically tailored information. Given the noted 
disconnect between perceived risks and actual HIV risk 
behaviors, further expansion of the scope of HIV educa-
tion is required to enable participants objectively assess and 
understand their HIV risks. For instance, models of esti-
mating actual risks [49] could be incorporated into educa-
tional efforts.
Limitations of the study
The study involved participants who were already in 
contact with peer outreach. It is therefore possible that 
this recruitment bias may have affected our results 
related to participants’ uptake of HIV testing and per-
ception towards peer-led community-based outreach. 
A reason for the finding that participants held the per-
ception that they had lower HIV risk compared to the 
general population may have related to their recent HIV 
testing. Moreover, the proportion of participants who 
were already HIV positive was not known as participants 
were not required to divulge their HIV status. Conse-
quently, the relationship between recent test results and 
risk perception could not be explored in this study. All 
participants were recruited in Phnom Penh, limiting 
generalizability to other people who use drugs nation-
ally. Participants in the focus groups were selected based 
on convenience, which may exacerbate this selection 
bias. Despite application of eligibility criteria designed 
to retain participants that were currently using drugs, 
a small minority reported they had not used any form 
of illicit drugs in the past 3  months. More broadly, the 
methodology used in this study largely depended on par-
ticipants self-reporting, and some participants skipped 
some questions, which may have introduced further 
limitations.
Implications for future research
Despite these limitations, our findings are consistent with 
research in Cambodia and elsewhere showing the effec-
tiveness of community-based outreach in reaching peo-
ple who use drugs [20, 50]. While this study reports on 
uptake of HIV testing, downstream data on linkage and 
retention on ART was unavailable, yet are central in the 
care continuum. Besides, the extent to which the pro-
gram contributed to achievement of the first 90 in the 
90–90–90 targets cannot be deduced because of lack of 
denominators and prior rates of testing. This is due to 
lack of local level strategic information regarding num-
bers of people at risk. Nationally, past efforts predomi-
nantly focused on increasing HIV testing, with significant 
limited focus on the continuum on local levels [23]. This 
was certainly the case in 2014 when this study was con-
ducted [23].
However, the Health Sector Strategic Plan IV (2015–
2020) includes strategies for improving the strategic 
information base as one of its cross-cutting strategy. 
Generation of localized data will enable programs moni-
tor their contributions to 90–90–90 targets better, within 
their catchment areas. In addition, focus on the care 
continuum is central to the relatively recent approach—
known as Boosted Continuum of Prevention to Care 
and Treatment—which aims to identify and reach new 
infections, ensure they are brought into care, and are 
retained in ART. This approach is targeted specifically 
to areas where new infections are occurring, among key 
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populations, and should therefore be central to future 
community-based outreach programming and research.
Conclusions
The findings of this study demonstrate that utilization 
of peer outreach and community infrastructure famil-
iar and close to people who use drugs such as drop-in 
centers could contribute to increasing uptake of HIV 
testing and other harm reduction interventions among 
these populations. Although the uptake of testing, 
needles, and syringes was high in this study, outstand-
ing HIV risks were identified. Additional strategies are 
required to ensure that people at risk are enabled to have 
an objective understanding of their HIV risks and vul-
nerabilities of people who use drugs are mitigated in the 
study context.
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